Discover Sanfilippo Syndrome a rare genetic disorder affecting childrens development Learn about its symptoms treatment ...
Hosted on MSN19d
Regenxbio and Nippon Shinyaku forge $810m gene therapy dealRegenxbio has entered into a strategic collaboration worth $810m with Japan-based Nippon Shinyaku to advance gene therapies targeting the rare metabolic disorder mucopolysaccharidosis (MPS).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback